Showing results (1161-1170 of 2,691) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|April 3, 2017
Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled studyXavier Sáez-Llorens, Vianney Tricou, Delia Yu, et al.
The Lancet. Infectious Diseases|April 3, 2017
Rocky Mountain spotted fever in Mexico: past, present, and futureGerardo Álvarez-Hernández, Jesús Felipe González Roldán, Néstor Saúl Hernández Milan, et al.
The Lancet. Infectious Diseases|October 8, 2019
Assessment of non-prescription antibiotic dispensing at community pharmacies in China with simulated clients: a mixed cross-sectional and longitudinal studyJie Chang, Sen Xu, Shan Zhu, et al.
The Lancet. Infectious Diseases|September 24, 2019
Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort studyCristina Domingo, Juliane Fraissinet, Patrick O Ansah, et al.
The Lancet. Infectious Diseases|September 28, 2019
Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trialDora Buonfrate, Joaquin Salas-Coronas, José Muñoz, et al.
The Lancet. Infectious Diseases|September 29, 2019
The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet. Infectious Diseases|September 22, 2019
Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort studyMatthew J Akiyama, Charles M Cleland, John A Lizcano, et al.
The Lancet. Infectious Diseases|April 1, 2008
Lessons from the past: managing insecticide resistance in malaria control and eradication programmesLouise Kelly-Hope, Hilary Ranson, Janet Hemingway
The Lancet. Infectious Diseases|March 28, 2014
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospectsAlimuddin I Zumla, Stephen H Gillespie, Michael Hoelscher, et al.
The Lancet. Infectious Diseases|February 1, 2017
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort studyCaroline Charlier, Élodie Perrodeau, Alexandre Leclercq, et al.
Pageof 270